Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study of Lurbinectedin and Irinotecan for Patients with Advanced Solid Tumors
Not recruiting
Investigated Drugs:
Study of JDQ443, TNO155, and Tislelizumab for Patients with Advanced Solid Tumors with KRAS G12C Mutation
Not recruiting
Investigated Diseases:Investigated Drugs:
+1
Study of ICT01 and Pembrolizumab for Patients with Advanced-Stage, Relapsed/Refractory Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Elraglusib Alone or with Chemotherapy for Patients with Refractory Blood Cancers or Solid Tumors
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on Atezolizumab and Tiragolumab for Patients with Head and Neck Cancer, Metastatic Melanoma, and Other Advanced Solid Tumors
Not recruiting
Investigated Diseases:Investigated Drugs:
